Cost-effectiveness of Catheter Ablation Versus Antiarrhythmic Drug Therapy for the Treatment of Atrial Fibrillation: A Canadian Perspective

Cost-effectiveness of Catheter Ablation Versus Antiarrhythmic Drug Therapy for the Treatment of Atrial Fibrillation: A Canadian Perspective

**Background:** Atrial fibrillation (AF) affects approximately 350,000 Canadians and has an estimated annual economic burden exceeding $800 million dollars. Anti-arrhythmic drug (AAD) therapy and catheter ablation (CA) are the two common treatments for paroxysmal AF. However, the upfront costs of CA...

Full description

Bibliographic Details
Main Authors: Yaariv Khaykin, Peter J. Mallow, John A. Rizzo, Atul Verma, Lauren Chun, Shelby Olesovsky, Matthew R. Reynolds
Format: Article
Language:English
Published: Columbia Data Analytics, LLC
Series:Journal of Health Economics and Outcomes Research
Online Access:http://jheor.scholasticahq.com/article/9837-cost-effectiveness-of-catheter-ablation-versus-antiarrhythmic-drug-therapy-for-the-treatment-of-atrial-fibrillation-a-canadian-perspective.pdf

Internet

http://jheor.scholasticahq.com/article/9837-cost-effectiveness-of-catheter-ablation-versus-antiarrhythmic-drug-therapy-for-the-treatment-of-atrial-fibrillation-a-canadian-perspective.pdf

Similar Items